BPH Stock Overview
Invests in biotechnology and oil and gas exploration and development industries in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
BPH Energy Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.012 |
| 52 Week High | AU$0.071 |
| 52 Week Low | AU$0.01 |
| Beta | 0.71 |
| 11 Month Change | 0% |
| 3 Month Change | -36.84% |
| 1 Year Change | -53.85% |
| 33 Year Change | -72.09% |
| 5 Year Change | 20.00% |
| Change since IPO | -99.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| BPH | AU Capital Markets | AU Market | |
|---|---|---|---|
| 7D | -4.0% | 1.1% | 1.5% |
| 1Y | -53.8% | 37.0% | 17.2% |
Return vs Industry: BPH underperformed the Australian Capital Markets industry which returned 37% over the past year.
Return vs Market: BPH underperformed the Australian Market which returned 17.2% over the past year.
Price Volatility
| BPH volatility | |
|---|---|
| BPH Average Weekly Movement | 16.6% |
| Capital Markets Industry Average Movement | 4.0% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: BPH's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: BPH's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | David Breeze | www.bphenergy.com.au |
BPH Energy Limited invests in biotechnology and oil and gas exploration and development industries in Australia. It also offers biomedical research services. The company was formerly known as BioPharmica Limited.
BPH Energy Limited Fundamentals Summary
| BPH fundamental statistics | |
|---|---|
| Market cap | AU$14.60m |
| Earnings (TTM) | AU$4.56m |
| Revenue (TTM) | AU$843.68k |
3.2x
P/E Ratio17.3x
P/S RatioIs BPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BPH income statement (TTM) | |
|---|---|
| Revenue | AU$843.68k |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$843.68k |
| Other Expenses | -AU$3.71m |
| Earnings | AU$4.56m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0037 |
| Gross Margin | 100.00% |
| Net Profit Margin | 540.13% |
| Debt/Equity Ratio | 0.3% |
How did BPH perform over the long term?
See historical performance and comparison